Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models.
Kerr CP, Sheehan-Klenk J, Grudzinski JJ, Adam DP, Nguyen TPT, Ferreira CA, Bates AM, Jin WJ, Kwon O, Olson AP, Lin W, Hyun M, Jagodinsky JC, Powers M, Sriramaneni RN, Clark PA, Shea AG, Rojas HC, Choi C, Massey CF, Zangl LM, Pinchuk AN, Aluicio-Sarduy E, Kim K, Engle JW, Hernandez R, Bednarz BP, Weichert JP, Morris ZS.
Kerr CP, et al. Among authors: jagodinsky jc.
bioRxiv [Preprint]. 2024 Jul 16:2024.07.10.602990. doi: 10.1101/2024.07.10.602990.
bioRxiv. 2024.
PMID: 39071353
Free PMC article.
Preprint.